Elite Pharma Inc (ELTP) stock news · rev $148.9M
Elite Pharma Inc (ELTP) is a drug manufacturers - specialty & generic company listed on US.
This ELTP news page leads with what Elite Pharma Inc filed — not a scraped headline mill.
No cached 8-K sentence for ELTP yet. We will not pad this page with generic market recap.
Latest reported ELTP revenue for 2026-03-31 was $148.9M. Net income was $44.9M. Revenue was up 77.1% from 2025-03-31 to 2026-03-31. ELTP currently screens at market cap $659.0M.
EDGAR remains the official archive. Lician caches the exhibit so you can read what changed without a wire story.
Not investment advice. For the model open the ELTP stock page; for the tape open the quote page.
Not investment advice.